MaxCyte appoints Madhusudan Peshwa VP

By siliconindia   |   Tuesday, 05 April 2005, 19:30 IST
Printer Print Email Email
GAITHERSBURG, MD:MaxCyte Inc., a clinical stage biotechnology company developing cell-based therapeutics, has appointed Madhusudan Peshwa as its vice president of research and development. Most recently, Peshwa was executive vice president of research and development at regenerative medicine company NewNeural LLC. Before that, he held positions as the vice president of manufacturing and vice president of process science at Dendreon Corp. Douglas A Doerfler, President and CEO of MaxCyte commented, “We are extremely excited that Peshwa has joined MaxCyte as he brings solid technical and commercial skills. His experience in delivering cell-based biologic products from concept through translational development and scale upto commercial implementation will be a valuable addition to the MaxCyte team.” Peshwa holds a PhD in Chemical Engineering from the University of Minnesota.